| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $778.9M | — | +6.5% |
| Cost of Revenue | $522.3M | — | +13.0% |
| Gross Profit | $256.6M | — | -4.8% |
| R&D Expense | $7.8M | — | -2.5% |
| SG&A Expense | $149.3M | — | +13.7% |
| Interest Expense | $39.1M | — | +5.7% |
| Pre-tax Income | -$4.8M | — | -115.9% |
| Income Tax | -$1.4M | — | -117.9% |
| Net Income | -$3.4M | — | -115.2% |
| EPS (Basic) | -$0.05 | — | -116.1% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $214.8M | -9.1% | +9.6% |
| Accounts Receivable | $372.8M | -7.8% | +6.6% |
| Inventory | $720.7M | -7.7% | +8.1% |
| Current Assets | $1.56B | -6.9% | +11.1% |
| Total Assets | $4.44B | -2.5% | +5.0% |
| Current Liabilities | $783.9M | -1.4% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $149.5M | — | +94.2% |
| Capital Expenditures | $25.3M | — | -26.9% |
| Investing Cash Flow | -$25.3M | — | +27.1% |
| Financing Cash Flow | -$145.8M | — | -159.9% |
| Free Cash Flow | $124.2M | — | +192.9% |
| +0.1% |
| Long-term Debt | $3.32B | -3.7% | +6.5% |
| Total Liabilities | $4.30B | -1.9% | +5.2% |
| Stockholders' Equity | $141.3M | -16.8% | +0.5% |